Antimicrobial Therapy for Pneumonia or Fluid Overload?

Patients with evidence of fluid overload or heart failure (HF) without clinical symptoms pneumonia are often treated antimicrobial therapy for pneumonia. We conducted a retrospective study to evaluate the use in critically ill patients diagnosed as A chart review on intensive care unit was conducted. The study's primary outcome number cases no pneumonia, including failure, managed other infections were excluded. Appropriateness based radiographic evidence, data, and presentation. Patient group categories (pneumonia) and B (no overload, failure). Based subdivision Group B, where there we further classified it into two subgroups: (HF)/fluid (Group B1) HF B2). A) compared B1). p-value < 0.05% considered significant detecting statistical difference. Post-screening, data 56 collected analyzed. Mean body temperature white blood cell count 37.6 + 0.6 oC, 17.4 6.88 x103 µL, respectively. Based presentation, 29 (52%) under A, while 27 (48%) B. Median brain natriuretic peptide (BNP) vs. 514 (IQR: 1077) 758 (2212) pg/mL p=0.14. The median duration inpatient 7 (interquartile range [IQR]: 6) 6 4) days, p=0.52, total (inpatient discharge prescription) was 11 11 5), p=0.21. BNP groups 1040 (2094) pg/mL, p=0.04. Patients documented echocardiographic ejection fraction 55% 4 14 Groups B1, respectively. Additionally, B2 189 (418) p=0.02. These findings demonstrate 48% inappropriate congestive (CHF), congestion misdiagnosed There difference observed those More elevated reduced left ventricular (LVEF) CHF than alone. Appropriate interpretation laboratory critical assessment empiric this population is warranted.